Gt Biopharma Inc share price logo

Gt Biopharma Inc Share Price

NASDAQ: GTBP

Small Cap

$0.82

+0.02

(+2.35%)

Live

as on

Gt Biopharma Inc Stock Performance

as on September 15, 2025 at 10:41 pm IST

  • Day's Low

    $0.78
    $0.82
    downward going graph

    4.88%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.63
    $4.1
    downward going graph

    23.13%

    Downside

    400.00%

    Upside

    downward going graph

Gt Biopharma Inc share price movements today

Previous Close
$0.81
Open
$0.80
Volume
203.5K
Day's Low - High
$0.78 - $0.82
52 Week Low - High
$0.63 - $4.1

Gt Biopharma Inc Historical Returns

1 Month Return
-39.93 %
3 Month Return
-71.65 %
1 Year Return
-63.07 %
3 Year Return
-98.7 %
5 Year Return
+ 373.53 %

Gt Biopharma Inc Stock Fundamentals & Key Indicators

Check Gt Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.9M

EPS (TTM)

-1.31

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-6.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

668800.00%

Gt Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gt Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.9M373.53%NA0.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Gt Biopharma Inc Stock including INR - Dollar returns

The Gt Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gt Biopharma Inc investment value today

Current value as on today

₹42,600

Returns

₹57,400

(-57.4%)

Returns from Gt Biopharma Inc Stock

₹62,385 (-62.39%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Gt Biopharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Gt Biopharma Inc. Average target price of $11

Gt Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Gt Biopharma Inc.

What analysts predicted

92.55%UPSIDE

Target Price

$11

Current Price

$0.82

Analyzed by

7 Analysts

Target

$11.00

Gt Biopharma Inc target price $11, a slight upside of 92.55% compared to current price of $0.82. According to 7 analysts rating.

Gt Biopharma Inc Stock's Interest Amongst Investors

Search interest for Gt Biopharma Inc Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:34% versus previous 30 day period

Gt Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-3
-3
-3
-3
-3
-3
-3
-3
-1
-1
EBITDA
0
-1
-2
-2
0
-3
-3
-3
-1
-1
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
0
-1
-2
-2
-2
-3
-3
-3
0
-1
Income Tax Expense
3
0
0
0
-3
-3
-
3
3
-
Net Income
0
-1
-2
-2
-2
-3
-3
-3
0
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Gt Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
-
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-
-
-
-
-
Operating Income
-8
-9
-135
-250
-16
-6
-57
-21
-13
-14
EBITDA
-8
-9
-135
-250
-11
-24
-57
-20
5
-13
Interest Expense
17
6
8
9
2
3
0
0
0
-
Depreciation
-
-
0
0
0
-
-
-
-
-
Income Before Tax
-21
9
-144
-259
-38
-28
-58
-20
-7
-13
Income Tax Expense
17
-30
7
-228
2
3
0
0
0
-
Net Income
-21
9
-144
-259
-38
-28
-58
-20
-7
-13
Net Profit Margin
-79485.19%
0.00%
-533970.37%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Gt Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-1
-2
-2
-2
-3
-3
-3
0
-1
Operating Cash Flow
-1
-1
-2
-4
-3
-2
-2
-2
-3
Investing Cash Flow
2
1
0
5
7
0
0
-
-
Financing Cash Flow
-
0
0
-
2
-
-
0
5
Change in Cash
0
0
-1
0
7
-2
-2
-1
2

Gt Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
21
-143
-259
-38
-28
-58
-20
-7
-13
Operating Cash Flow
-1
-5
-10
-3
-7
-15
-15
-8
-12
Investing Cash Flow
0
0
0
0
-23
-23
12
-2
12
Financing Cash Flow
1
5
10
3
12
42
0
6
2
Change in Cash
0
0
0
0
5
3
-3
-4
2

Global Institutional Holdings in Gt Biopharma Inc

Funds
Holdings
Geode Capital Management, LLC
0.71%
Citadel Advisors Llc
0.62%
Bank of Montreal
0.45%
BMO Capital Markets Corp.
0.45%
Vanguard Group Inc
0.32%

Insights on Gt Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 222.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 138.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, GTBP stock has moved down by -6.6%

About Gt Biopharma Inc

using our proprietary platform technology, gt biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute myeloid leukemia, myeloid dysplastic syndrome, and multiple solid tumors by leveraging our proprietary nk cell engager (trike) platform technology. (nasdaq: gtbp)
OrganisationGt Biopharma Inc
Headquarters315 Montgomery Street, San Francisco, CA, United States, 94104
IndustryPharmaceuticals: Other
CEOMr. Michael Martin Breen L.L.B.
E-voting on sharesClick here to vote

Key Management of Gt Biopharma Inc

Name

Title

Mr. Michael Martin Breen L.L.B.

CEO & Executive Chairman

Mr. Alan Louis Urban CPA

CFO & Secretary

FAQs

What is Gt Biopharma Inc share price today?

Gt Biopharma Inc share price today is $0.82 as on . Gt Biopharma Inc share today touched a day high of $0.82 and a low of $0.78.

What is the 52 week high and 52 week low for Gt Biopharma Inc share?

Gt Biopharma Inc share touched a 52 week high of $4.1 on and a 52 week low of $0.63 on . Gt Biopharma Inc stock price today i.e. is trending at $0.82,which is 80.00% down from its 52 week high and 30.10% up from its 52 week low.

What is Gt Biopharma Inc's market capitalisation today?

Gt Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Gt Biopharma Inc Stock (GTBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gt Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gt Biopharma Inc Shares that will get you 1.8293 shares as per Gt Biopharma Inc share price of $0.82 per share as on September 15, 2025 at 10:41 pm IST.

What is the minimum amount required to buy Gt Biopharma Inc Stock (GTBP) from India?

Indian investors can start investing in Gt Biopharma Inc (GTBP) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Gt Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Gt Biopharma Inc share’s latest price of $0.82 as on September 15, 2025 at 10:41 pm IST, you will get 12.1951 shares of Gt Biopharma Inc. Learn more about fractional shares .

What are the returns that Gt Biopharma Inc has given to Indian investors in the last 5 years?

Gt Biopharma Inc stock has given 373.53% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?